MedPath

Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.

Not Applicable
Conditions
Implant Breast Reconstruction
Bovine Pericardial Patch
TiLOOP® Bra Mesh
Interventions
Procedure: TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction
Procedure: Bovine Pericardial Patch in Immediate Implant Breast Reconstruction
Registration Number
NCT04245930
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Brief Summary

This study is the first randomized and controlled study assessing the efficacy and safety of bovine pericardial patch and TiLOOP® bra mesh in patients with immediate implant breast reconstruction

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
176
Inclusion Criteria
  1. Patients diagnosed with I~II stage breast cancer and Intent to receive NSM or SSM and implant based breast reconstruction
  2. Do not smoking in the last 4 weeks or more
  3. Mental health patients
  4. Signed consent to participate
Exclusion Criteria
  1. Locally advanced stage patients or patients with distal metastasis
  2. Patients received thoracic wall radiotherapy or will receive radiotherapy
  3. Smoking in the last 4 weeks
  4. Anticipated implant volume more than 600cc
  5. Patients of pregnancy or lactation
  6. Patients received neoadjuvant therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TiLOOP® Bra MeshTiLOOP® Bra Mesh in Immediate Implant Breast ReconstructionImmediate implant breast reconstruction using TiLOOP® Bra Mesh. n=88
Bovine Pericardial PatchBovine Pericardial Patch in Immediate Implant Breast ReconstructionImmediate implant breast reconstruction using bovine pericardial patch. n=88
Primary Outcome Measures
NameTimeMethod
Complication Ratesup to 12 months after surgery

The rate of complications in the two groups

Secondary Outcome Measures
NameTimeMethod
Cosmetic outcome of reconstructed breastImmediately, up to 3 months, 6 months and 12 months after surgery

Harris evaluation score was used to evaluate the aesthetic outcome of patients' reconstructed breasts, which was scored as "excellent," "good," "fair," "poor".

Health economics-inpatient costup to 12 months after surgery, including the cost of surgical revision

Hospital inpatient costs due to immediate implant breast reconstruction

Patient satisfaction-Breast-Q questionnaireup to 12 months after surgery

We use the Breast-Q questionnaire to evaluate patients' satisfaction via the reconstruction module of BREAST-Q.

The rate of surgical revision of reconstructed breastsup to 12 months after surgery

To record the rate of surgical revision events of the reconstructed breasts

Trial Locations

Locations (1)

Tianjin Medical University Cancer Institute and Hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath